Agile Therapeutics reported $-16772000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Aceto ACET:US -14013000 3.16M
Adma Biologics ADMA:US $ -17.71M 1.19M
Agile Therapeutics AGRX:US $ -16.77M 0.86M
Bayer BAYN:GR € 85M 2420M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Johnson & Johnson JNJ:US $ 3667M 2611M
Merk MRK:US $ 4567M 3022M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Pain Therapeutics PTIE:US $ -9.56M 4.44M
Pfizer PFE:US $ 8146M 2582M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
Therapeuticsmd TXMD:US -47420000 4.77M